News – Page 142 – Endpoints News

Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau

11 months ago

CordenPharma injects €900M to boost GLP-1 manufacturing in US and Europe

11 months ago

Exclusive: Kins raises $7M to expand in-home and virtual physical therapy

11 months ago

Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year

11 months ago

Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab

11 months ago

J&J calls proposed class action talc suit 'meritless' as settlement vote deadline nears

11 months ago

EMA warns patients to tell doctors about GLP-1 usage before surgery

11 months ago

Revolution Medicines' RAS inhibitor shows promise in early-stage pancreatic cancer trial

11 months ago

Evofem inks women’s health deal; AusperBio brings in $37M

11 months ago

Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data

11 months ago

Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline

11 months ago

GSK HQ officially returns to central London after decades in city’s suburbs

11 months ago

Deep dive on pay packages; Lilly strikes $3.2B buyout; Pfizer’s R&D head to depart; and more

11 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

11 months ago

Indivior axes schizophrenia drug and shrinks revenue guidance

11 months ago

Two healthcare SPACs go public, with several more on the hunt for deals

11 months ago

How SCOTUS' decision in Chevron could change the way the FDA regulates biopharma

11 months ago

Metagenomi science chief departs, just a few months after IPO

11 months ago

Ideaya raises $302M; AbbVie to seek approval in giant cell arteritis

11 months ago

Spinouts, pension reforms and a GSK vet in cabinet: What the new UK government could mean for life sciences

11 months ago

Immutep’s LAG-3 drug scores in Phase 2b head and neck cancer test

11 months ago

Mikael Dolsten isn’t the only one moving on from Pfizer; Lilly names interim finance chief

11 months ago

Roche's gene therapy biotech Spark is laying off employees, ending some early-stage programs

11 months ago

AbbVie asks Supreme Court to reconsider ruling on attorney-client communication

11 months ago

First page Previous page 139 140 141142143 144 145 Next page Last page